Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
A phase 2 trial of Cisplatin, Carboplatin, Paclitaxel / nab-paclitaxel in cervical cancer and head and neck squamous cell carcinoma, run by AstraZeneca, now recruiting.
Overview
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors is a phase 2 interventional study registered as NCT06535607 by AstraZeneca, with 257 participants planned, started 2024-08-22 and due to reach its primary completion in 2028-11-30. Interventions recorded: Volrustomig, Cisplatin, Carboplatin, Paclitaxel, 5-FU. Conditions listed: Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin.
- TrialA Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the
Shares Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin, Cervical cancer.
- TrialMEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Shares Mesothelioma, Cisplatin, AstraZeneca, Carboplatin.
- TrialBAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Shares Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin, Cervical cancer.
- TrialA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Canc
Shares Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin, Cervical cancer.
- TrialA Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Shares Paclitaxel / nab-paclitaxel, Cisplatin, AstraZeneca, Carboplatin.
- TrialAK129 Combination Therapy for Advanced Solid Tumors
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Paclitaxel / nab-paclitaxel, Carboplatin, Head and neck squamous cell carcinoma.
- TrialStudy of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
Shares Paclitaxel / nab-paclitaxel, Cisplatin, AstraZeneca, Carboplatin.